{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:46:38Z","timestamp":1770518798939,"version":"3.49.0"},"reference-count":34,"publisher":"Biomedical Research Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed. Res."],"published-print":{"date-parts":[[2026,1,31]]},"DOI":"10.2220\/biomedres.47.11","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T22:08:34Z","timestamp":1769983714000},"page":"11-23","source":"Crossref","is-referenced-by-count":0,"title":["Tenascin-XB plays a role in the infiltration of immune cells in tumor microenvironment"],"prefix":"10.2220","volume":"47","author":[{"given":"Ao","family":"GONG","sequence":"first","affiliation":[{"name":"Department of Biosignaling and Radioisotope Experiment, Interdisciplinary Center for Science Research, Head Office for Research and Academic Information, Shimane University, 89-1 Enya-cho, Izumo 693-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"IIDA","sequence":"additional","affiliation":[{"name":"Department of Immunology, Shimane University Faculty of Medicine, 89-1 Enya-cho, Izumo 693-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"KAWAKAMI","sequence":"additional","affiliation":[{"name":"Department of Experimental Animals, Interdisciplinary Center for Science Research, Head Office for Research and Academic Information, Shimane University, 89-1 Enya-cho, Izumo 693-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"YAMADA","sequence":"additional","affiliation":[{"name":"Department of Biosignaling and Radioisotope Experiment, Interdisciplinary Center for Science Research, Head Office for Research and Academic Information, Shimane University, 89-1 Enya-cho, Izumo 693-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"SAITO","sequence":"additional","affiliation":[{"name":"Department of Immunology, Shimane University Faculty of Medicine, 89-1 Enya-cho, Izumo 693-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"MATSUMOTO","sequence":"additional","affiliation":[{"name":"Department of Biosignaling and Radioisotope Experiment, Interdisciplinary Center for Science Research, Head Office for Research and Academic Information, Shimane University, 89-1 Enya-cho, Izumo 693-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1059","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Ahmed H, Mahmud AR, Siddiquee MF, Shahriar A, Biswas P, et al. (2022) Role of T cells in cancer immunotherapy: Opportunities and challenges. Cancer Pathog Ther 1, 116\u2013126.","DOI":"10.1016\/j.cpt.2022.12.002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Brellier F and Chiquet-Ehrismann R (2012) How do tenascins influence the birth and life of a malignant cell?. J Cell Mol Med 16, 32\u201340.","DOI":"10.1111\/j.1582-4934.2011.01360.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bristow J, Carey W, Egging D and Schalkwijk J (2005) Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet 139C, 24\u201330.","DOI":"10.1002\/ajmg.c.30071"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chakravarthy A, Khan L, Bensler NP, Bose P and De Carvalho DD (2018) TGF-\u03b2-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure. Nat Commun 9, 4692.","DOI":"10.1038\/s41467-018-06654-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chiquet-Ehrismann R and Tucker RP (2011) Tenascins and the importance of adhesion modulation. Cold Spring Harb Perspect Biol 3, a004960.","DOI":"10.1101\/cshperspect.a004960"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Demirdas S, Dulfer E, Robert L, Kempers M, van Beek D, et al. (2017) Recognizing the tenascin-X deficient type of Ehlers-Danlos syndrome: a cross-sectional study in 17 patients. Clin Genet 91, 411\u2013425.","DOI":"10.1111\/cge.12853"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Eble JA and Niland S (2019) The extracellular matrix in tumor progression and metastasis. Clin Exp Metastasis 36, 171\u2013 198.","DOI":"10.1007\/s10585-019-09966-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Geffrotin C, Garrido JJ, Tremet L and Vaiman M (1995) Distinct tissue distribution in pigs of tenascin-X and tenascin-C transcripts. Eur J Biochem 231, 83\u201392.","DOI":"10.1111\/j.1432-1033.1995.tb20673.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Hanahan D and Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309\u2013322.","DOI":"10.1016\/j.ccr.2012.02.022"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Huang J, Zhang L, Wan D, Zhou L, Zheng S, et al. (2021) Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther 6, 153.","DOI":"10.1038\/s41392-021-00544-0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Kuczek DE, Larsen AMH, Thorseth ML, Carretta M, Kalvisa A, et al. (2019) Collagen density regulates the activity of tumor-infiltrating T cells. J Immunother Cancer 7, 68.","DOI":"10.1186\/s40425-019-0556-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Lee CJ, Jang TY, Jeon SE, Yun HJ, Cho YH, et al. (2024) The dysadherin\/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression. Nat Commun 15, 10422.","DOI":"10.1038\/s41467-024-54920-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT Method. Methods 25, 402\u2013408.","DOI":"10.1006\/meth.2001.1262"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Malfait F, Castori M, Francomano CA, Giunta C, Kosho T, et al. (2020) The Ehlers-Danlos syndromes. Nat Rev Dis Primers 6, 64.","DOI":"10.1038\/s41572-020-0194-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Matsumoto K, Takayama N, Ohnishi J, Ohnishi E, Shirayoshi Y, et al. (2001) Tumour invasion and metastasis are promoted in mice deficient in tenascin-X. Genes Cells 6, 1101\u20131111.","DOI":"10.1046\/j.1365-2443.2001.00482.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Matsumoto K, Minamitani T, Orba Y, Sato M, Sawa H, et al. (2004) Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathway. Exp Cell Res 297, 404\u2013414.","DOI":"10.1016\/j.yexcr.2004.03.041"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Matsumoto K, Sato T, Oka S, Inokuchi J and Ariga H (2004) Comparison of the compositions of phospholipid-associated fatty acids in wild-type and extracellular matrix tenascin-X-deficient mice. Biol Pharm Bull 27, 1447\u20131450.","DOI":"10.1248\/bpb.27.1447"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Matsumoto K, Kinoshita T, Hirose T and Ariga H (2006) Characterization of mouse serum tenascin-X. DNA Cell Biol 25, 448\u2013456.","DOI":"10.1089\/dna.2006.25.448"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Matsumoto K and Aoki H (2020) The roles of tenascins in cardiovascular, inflammatory, and heritable connective tissue diseases. Front Immunol 11, 609752.","DOI":"10.3389\/fimmu.2020.609752"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Murdamoothoo D, Sun Z, Yilmaz A, Riegel G, Abou-Faycal C, et al. (2021) Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression. EMBO Mol Med 13, e13270.","DOI":"10.15252\/emmm.202013270"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Okuda-Ashitaka E and Matsumoto K (2023) Tenascin-X as a causal gene for classical-like Ehlers-Danlos syndrome. Front Genet 14, 1107787.","DOI":"10.3389\/fgene.2023.1107787"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Pickup MW, Mouw JK and Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15, 1243\u20131253.","DOI":"10.15252\/embr.201439246"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Raskov H, Orhan A, Christensen JP and G\u00f6genur I (2021) Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. Br J Cancer 124, 359\u2013367.","DOI":"10.1038\/s41416-020-01048-4"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Salmon H, Franciszkiewicz K, Damotte D, Dieu-Nosjean MC, Validire P, et al. (2012) Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest 122, 899\u2013910.","DOI":"10.1172\/JCI45817"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Sorokin L (2010) The impact of the extracellular matrix on inflammation. Nat Rev Immunol 10, 712\u2013723.","DOI":"10.1038\/nri2852"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Spenl\u00e9 C, Saupe F, Midwood K, Burckel H, Noel G, et al. (2015) Tenascin-C: Exploitation and collateral damage in cancer management. Cell Adh Migr 9, 141\u2013153.","DOI":"10.1080\/19336918.2014.1000074"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Spenl\u00e9 C, Loustau T, Murdamoothoo D, Erne W, Beghelli-de la Forest Divonne S, et al. (2020) Tenascin-C orchestrates an immune-suppressive tumor microenvironment in oral squamous cell carcinoma. Cancer Immunol Res 8, 1122\u20131138.","DOI":"10.1158\/2326-6066.CIR-20-0074"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Tucker RP and Degen M (2019) The expression and possible functions of tenascin-W during development and disease. Front Cell Dev Biol 7, 53.","DOI":"10.3389\/fcell.2019.00053"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Valcourt U, Alcaraz LB, Exposito JY, Lethias C and Bartholin L (2015) Tenascin-X: beyond the architectural function. Cell Adh Migr 9, 154\u2013165.","DOI":"10.4161\/19336918.2014.994893"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Waldman AD, Fritz JM and Lenardo MJ (2020) A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol 20, 651\u2013668.","DOI":"10.1038\/s41577-020-0306-5"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Yang N, Tian J, Wang X, Mei S, Zou D, et al. (2020) A functional variant in TNXB promoter associates with the risk of esophageal squamous-cell carcinoma. Mol Carcinog 59, 439\u2013446.","DOI":"10.1002\/mc.23166"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Yuan Z, Li Y, Zhang S, Wang X, Dou H, et al. (2023) Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol Cancer 22, 48.","DOI":"10.1186\/s12943-023-01744-8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Zhang N, Hartig H, Dzhagalov I, Draper D and He YW (2005) The role of apoptosis in the development and function of T lymphocytes. Cell Res 15, 749\u2013769.","DOI":"10.1038\/sj.cr.7290345"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Liot S, Aubert A, Hervieu V, Kholti NE, Schalkwijk J, et al. (2020) Loss of tenascin-X expression during tumor progression: A new pan-cancer marker. Matrix Biol Plus 6\u20137, 100021.","DOI":"10.1016\/j.mbplus.2020.100021"}],"container-title":["Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/47\/1\/47_11\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:37:45Z","timestamp":1770439065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/47\/1\/47_11\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2220\/biomedres.47.11","relation":{},"ISSN":["0388-6107","1880-313X"],"issn-type":[{"value":"0388-6107","type":"print"},{"value":"1880-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]}}}